Unraveling the molecular interactions between α7 nicotinic receptor and a RIC3 variant associated with backward speech.
Pradhan A. et al, (2024), Cell Mol Life Sci, 81
IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation.
Cao M. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10
NSC-87877, INHIBITOR OF SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHOTYROSINE PHOSPHATASE 2, AMELIORATES EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS INDUCED BY MUSK IMMUNIZATION
Yilmaz V. et al, (2022), MUSCLE & NERVE, 65, S45 - S45
The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle.
Cetin H. et al, (2020), Front Mol Neurosci, 13
Interaction of Axonal Chondrolectin with Collagen XIXa1 Is Necessary for Precise Neuromuscular Junction Formation.
Oprişoreanu A-M. et al, (2019), Cell Rep, 29, 1082 - 1098.e10
Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes
Webster R., (2018), International Journal of Molecular Sciences, 19, 1326 - 1326
Serological and experimental studies in different forms of myasthenia gravis
Vincent A. et al, (2018), Annals of the New York Academy of Sciences, 1413, 143 - 153
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
Saxena A. et al, (2017), Scientific Reports, 7
Multiple roles of integrin-α3 at the neuromuscular junction
Ross JA. et al, (2017), Journal of Cell Science, 130, 1772 - 1784
Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface
Webster R. et al, (2014), Neuromuscular Disorders, 24, 143 - 147
A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment
Webster RG. et al, (2013), Experimental Neurology, 248, 286 - 298
Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR
Zoltowska K. et al, (2013), Human Molecular Genetics, 22, 2905 - 2913
Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol
Finlayson S. et al, (2013), Muscle & Nerve, 47, 279 - 282
FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
Finlayson S. et al, (2012), Journal of Neurology, Neurosurgery & Psychiatry, 83, A23.1 - A23
Presence and Pathogenic Relevance of Antibodies to Clustered Acetylcholine Receptor in Ocular and Generalized Myasthenia Gravis
Jacob S. et al, (2012), Archives of Neurology, 69
A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance
Webster R. et al, (2012), Brain, 135, 1070 - 1080
Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects
Viegas S. et al, (2012), Experimental Neurology, 234, 506 - 512
A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance
Webster R. et al, (2012), Brain, 135, 1070 - 1080
P23 Fluorescent receptors to light up the neuromuscular junction
Cossins J. et al, (2011), Neuromuscular Disorders, 21, S12 - S13